ARCHIVES

No Benefit For Cetuximab In Early-Stage Colon Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

AICR Increasing Funds for Research, Education, Supports Successful Symposium

November 7, 1986

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

November 21, 2014

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007

Switch To NTP Holds Down Entry Of New Compounds; Obey Supports NCI On Need For More Positions

March 16, 1979

New Subcommittee Chairman Named

June 10, 1977